Aby Buchbinder
2011
In 2011, Aby Buchbinder earned a total compensation of $634.5K as Former Vice President, Clinical Development at Enzon Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $95,000 |
|---|---|
| Salary | $349,789 |
| Stock Awards | $179,140 |
| Other | $10,596 |
| Total | $634,525 |
Buchbinder received $349.8K in salary, accounting for 55% of the total pay in 2011.
Buchbinder also received $95K in non-equity incentive plan, $179.1K in stock awards and $10.6K in other compensation.
Rankings
In 2011, Aby Buchbinder's compensation ranked 7,294th out of 10,747 executives tracked by ExecPay. In other words, Buchbinder earned more than 32.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,294 out of 10,747 | 32nd |
Division Manufacturing | 2,667 out of 3,960 | 33rd |
Major group Chemicals And Allied Products | 652 out of 1,033 | 37th |
Industry group Drugs | 451 out of 781 | 42nd |
Industry Biological Products, Except Diagnostic Substances | 75 out of 157 | 52nd |
Source: SEC filing on April 16, 2014.
Buchbinder's colleagues
We found three more compensation records of executives who worked with Aby Buchbinder at Enzon Pharmaceuticals in 2011.